Afuco™ Anti-Human CA12 ADCC Therapeutic Antibody (Helmholtz 6A10), ADCC Enhanced
Anti-CA12 ADCC Enhanced Antibody (Helmholtz 6A10) is an ADCC enhanced antibody produced by our Afuco™ platform. 6A10 is the first CA XII-specific inhibitory monoclonal antibody, offered an opportunity to evaluate this strategy with regard to CA XII-mediated catalysis. 6A10 inhibited exofacial CA activity in CA XII-expressing cancer cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-082CL |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CA12 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Open under aseptic conditions. |